Publication date: 28 February 2026
CRISPR–Cas9 screening identifies CLCC1 as a factor that increases neutral lipid flux to prevent hepatic steatosis and promotes nuclear pore complex assembly by promoting membrane bending and fusion.
Мерц резко сменил риторику во время встречи в Китае09:25，推荐阅读91视频获取更多信息
Strategic Account Management:，详情可参考heLLoword翻译官方下载
FT Videos & Podcasts
Израиль нанес удар по Ирану09:28。业内人士推荐搜狗输入法2026作为进阶阅读